JP2019515777A - 脳波計測のための装置及び方法 - Google Patents
脳波計測のための装置及び方法 Download PDFInfo
- Publication number
- JP2019515777A JP2019515777A JP2019511810A JP2019511810A JP2019515777A JP 2019515777 A JP2019515777 A JP 2019515777A JP 2019511810 A JP2019511810 A JP 2019511810A JP 2019511810 A JP2019511810 A JP 2019511810A JP 2019515777 A JP2019515777 A JP 2019515777A
- Authority
- JP
- Japan
- Prior art keywords
- brain
- data
- processing unit
- comparison
- stimulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000005259 measurement Methods 0.000 title claims abstract description 21
- 238000000034 method Methods 0.000 title description 8
- 239000003193 general anesthetic agent Substances 0.000 claims abstract description 89
- 230000000638 stimulation Effects 0.000 claims abstract description 81
- 210000004556 brain Anatomy 0.000 claims abstract description 73
- 238000012545 processing Methods 0.000 claims abstract description 53
- 230000003925 brain function Effects 0.000 claims abstract description 47
- 230000000694 effects Effects 0.000 claims description 36
- 230000037046 slow wave activity Effects 0.000 claims description 33
- 230000006870 function Effects 0.000 claims description 25
- 230000007177 brain activity Effects 0.000 claims description 19
- 230000001537 neural effect Effects 0.000 claims description 12
- 238000004590 computer program Methods 0.000 claims description 10
- 238000001514 detection method Methods 0.000 claims description 10
- 230000015654 memory Effects 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 7
- 230000000474 nursing effect Effects 0.000 claims description 6
- 229940079593 drug Drugs 0.000 description 24
- 239000003814 drug Substances 0.000 description 24
- 238000001802 infusion Methods 0.000 description 20
- 206010002091 Anaesthesia Diseases 0.000 description 18
- 230000037005 anaesthesia Effects 0.000 description 18
- 230000008859 change Effects 0.000 description 13
- 230000001629 suppression Effects 0.000 description 11
- 238000004393 prognosis Methods 0.000 description 10
- 229960004134 propofol Drugs 0.000 description 10
- OLBCVFGFOZPWHH-UHFFFAOYSA-N propofol Chemical compound CC(C)C1=CC=CC(C(C)C)=C1O OLBCVFGFOZPWHH-UHFFFAOYSA-N 0.000 description 10
- 238000011084 recovery Methods 0.000 description 10
- 230000000926 neurological effect Effects 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 241000282412 Homo Species 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000003371 gabaergic effect Effects 0.000 description 6
- 210000004761 scalp Anatomy 0.000 description 6
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 description 5
- 230000003444 anaesthetic effect Effects 0.000 description 5
- 230000005978 brain dysfunction Effects 0.000 description 5
- 208000029028 brain injury Diseases 0.000 description 5
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 5
- 230000005855 radiation Effects 0.000 description 5
- 238000002604 ultrasonography Methods 0.000 description 5
- 206010010071 Coma Diseases 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 4
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000006931 brain damage Effects 0.000 description 4
- 231100000874 brain damage Toxicity 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 230000001037 epileptic effect Effects 0.000 description 4
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000001990 intravenous administration Methods 0.000 description 4
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 4
- 229940005483 opioid analgesics Drugs 0.000 description 4
- 238000010837 poor prognosis Methods 0.000 description 4
- 239000002269 analeptic agent Substances 0.000 description 3
- 210000005013 brain tissue Anatomy 0.000 description 3
- HRLIOXLXPOHXTA-NSHDSACASA-N dexmedetomidine Chemical compound C1([C@@H](C)C=2C(=C(C)C=CC=2)C)=CN=C[N]1 HRLIOXLXPOHXTA-NSHDSACASA-N 0.000 description 3
- 229960004253 dexmedetomidine Drugs 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 210000002569 neuron Anatomy 0.000 description 3
- 238000012876 topography Methods 0.000 description 3
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 description 2
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 description 2
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 2
- 208000010496 Heart Arrest Diseases 0.000 description 2
- 206010070511 Hypoxic-ischaemic encephalopathy Diseases 0.000 description 2
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 2
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 2
- NZXKDOXHBHYTKP-UHFFFAOYSA-N Metohexital Chemical compound CCC#CC(C)C1(CC=C)C(=O)NC(=O)N(C)C1=O NZXKDOXHBHYTKP-UHFFFAOYSA-N 0.000 description 2
- IDBPHNDTYPBSNI-UHFFFAOYSA-N N-(1-(2-(4-Ethyl-5-oxo-2-tetrazolin-1-yl)ethyl)-4-(methoxymethyl)-4-piperidyl)propionanilide Chemical compound C1CN(CCN2C(N(CC)N=N2)=O)CCC1(COC)N(C(=O)CC)C1=CC=CC=C1 IDBPHNDTYPBSNI-UHFFFAOYSA-N 0.000 description 2
- ZTVQQQVZCWLTDF-UHFFFAOYSA-N Remifentanil Chemical compound C1CN(CCC(=O)OC)CCC1(C(=O)OC)N(C(=O)CC)C1=CC=CC=C1 ZTVQQQVZCWLTDF-UHFFFAOYSA-N 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- IUJDSEJGGMCXSG-UHFFFAOYSA-N Thiopental Chemical compound CCCC(C)C1(CC)C(=O)NC(=S)NC1=O IUJDSEJGGMCXSG-UHFFFAOYSA-N 0.000 description 2
- 230000001800 adrenalinergic effect Effects 0.000 description 2
- 229960001391 alfentanil Drugs 0.000 description 2
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 229960003537 desflurane Drugs 0.000 description 2
- DPYMFVXJLLWWEU-UHFFFAOYSA-N desflurane Chemical compound FC(F)OC(F)C(F)(F)F DPYMFVXJLLWWEU-UHFFFAOYSA-N 0.000 description 2
- 230000005670 electromagnetic radiation Effects 0.000 description 2
- 238000002567 electromyography Methods 0.000 description 2
- NPUKDXXFDDZOKR-LLVKDONJSA-N etomidate Chemical compound CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1 NPUKDXXFDDZOKR-LLVKDONJSA-N 0.000 description 2
- 229960001690 etomidate Drugs 0.000 description 2
- 229960002428 fentanyl Drugs 0.000 description 2
- PJMPHNIQZUBGLI-UHFFFAOYSA-N fentanyl Chemical compound C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 PJMPHNIQZUBGLI-UHFFFAOYSA-N 0.000 description 2
- 210000005153 frontal cortex Anatomy 0.000 description 2
- 229960002725 isoflurane Drugs 0.000 description 2
- 229960003299 ketamine Drugs 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 229960002683 methohexital Drugs 0.000 description 2
- 229960005181 morphine Drugs 0.000 description 2
- 238000002610 neuroimaging Methods 0.000 description 2
- 230000003955 neuronal function Effects 0.000 description 2
- 230000037053 non-rapid eye movement Effects 0.000 description 2
- 239000013307 optical fiber Substances 0.000 description 2
- 229960003394 remifentanil Drugs 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 229960002078 sevoflurane Drugs 0.000 description 2
- DFEYYRMXOJXZRJ-UHFFFAOYSA-N sevoflurane Chemical compound FCOC(C(F)(F)F)C(F)(F)F DFEYYRMXOJXZRJ-UHFFFAOYSA-N 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000021 stimulant Substances 0.000 description 2
- 229960004739 sufentanil Drugs 0.000 description 2
- GGCSSNBKKAUURC-UHFFFAOYSA-N sufentanil Chemical compound C1CN(CCC=2SC=CC=2)CCC1(COC)N(C(=O)CC)C1=CC=CC=C1 GGCSSNBKKAUURC-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 229960003279 thiopental Drugs 0.000 description 2
- 229910052724 xenon Inorganic materials 0.000 description 2
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 208000020925 Bipolar disease Diseases 0.000 description 1
- 208000002381 Brain Hypoxia Diseases 0.000 description 1
- 206010010305 Confusional state Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000009829 Lewy Body Disease Diseases 0.000 description 1
- 201000002832 Lewy body dementia Diseases 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- HOKKHZGPKSLGJE-UHFFFAOYSA-N N-methyl-D-aspartic acid Natural products CNC(C(O)=O)CC(O)=O HOKKHZGPKSLGJE-UHFFFAOYSA-N 0.000 description 1
- 208000037212 Neonatal hypoxic and ischemic brain injury Diseases 0.000 description 1
- 208000004957 Out-of-Hospital Cardiac Arrest Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010069141 Septic encephalopathy Diseases 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 208000030886 Traumatic Brain injury Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010047115 Vasculitis Diseases 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000009973 brain hypoxia - ischemia Diseases 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 210000000852 deltoid muscle Anatomy 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000001490 effect on brain Effects 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000000537 electroencephalography Methods 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000001652 frontal lobe Anatomy 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000007386 hepatic encephalopathy Diseases 0.000 description 1
- 230000002631 hypothermal effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000007913 intrathecal administration Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 239000004081 narcotic agent Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000008035 nerve activity Effects 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000007658 neurological function Effects 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 208000033300 perinatal asphyxia Diseases 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 238000011524 similarity measure Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 230000002739 subcortical effect Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000003478 temporal lobe Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000009529 traumatic brain injury Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/369—Electroencephalography [EEG]
- A61B5/377—Electroencephalography [EEG] using evoked responses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4821—Determining level or depth of anaesthesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M19/00—Local anaesthesia; Hypothermia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36025—External stimulators, e.g. with patch electrodes for treating a mental or cerebral condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36082—Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/004—Magnetotherapy specially adapted for a specific therapy
- A61N2/006—Magnetotherapy specially adapted for a specific therapy for magnetic stimulation of nerve tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0618—Psychological treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0622—Optical stimulation for exciting neural tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/067—Radiation therapy using light using laser light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/06—Head
- A61M2210/0693—Brain, cerebrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/005—Parameter used as control input for the apparatus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/08—Other bio-electrical signals
- A61M2230/10—Electroencephalographic signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/063—Radiation therapy using light comprising light transmitting means, e.g. optical fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0645—Applicators worn by the patient
- A61N2005/0647—Applicators worn by the patient the applicator adapted to be worn on the head
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0651—Diodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0004—Applications of ultrasound therapy
- A61N2007/0021—Neural system treatment
- A61N2007/0026—Stimulation of nerve tissue
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Pathology (AREA)
- Anesthesiology (AREA)
- Biophysics (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Neurology (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Developmental Disabilities (AREA)
- Child & Adolescent Psychology (AREA)
- Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Social Psychology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Optics & Photonics (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Diabetes (AREA)
- Electrotherapy Devices (AREA)
- Magnetic Treatment Devices (AREA)
Abstract
Description
100B ユーザインタフェース
102 電極システム
104 注入ポンプ
106 計測装置
108 人体
110 人間
112 刺激装置
200 コイル
300 電極
400 超音波振動子
500 投与装置
600 プロセッサ
602 メモリ
Claims (13)
- データ処理部と、刺激装置とを備える装置であって、
前記データ処理部は、
1つ以上の非ゼロ量の麻酔薬物を投与された人間の脳の計測値に基づく第1の脳波データを受信し、
前記第1の脳波データと基準脳機能の対応するデータとの第1の比較を行い、
前記第1の比較についての情報を出力するよう構成され、
前記刺激装置は、前記麻酔薬物を投与された前記人間の脳に、前記第1の比較についての情報に基づく脳刺激を提供するよう構成される、
装置。 - 前記データ処理部は、
前記第1の脳波データの徐波活動に基づいて、前記麻酔薬物の投与と組み合わせて、第1の結果データを形成し、
前記第1の結果データが、前記基準脳機能の前記対応するデータから乖離しているか否かの検出を行い、及び、
前記乖離についての情報を含む第1の比較を出力するよう構成される、
請求項1に記載の装置。 - 前記刺激装置は、
前記装置のユーザインターフェースを介して看護スタッフから前記第1の比較についての情報を受信することと、
前記データ処理部と前記刺激装置との間の操作的接続を介して前記データ処理部から前記第1の比較についての情報を受信することと
の中の少なくとも1つを行うよう構成される、
ここで、前記ユーザインターフェースは前記第1の比較についての出力情報を前記看護スタッフに提示する、
請求項1に記載の装置。 - 前記データ処理部は、
徐波活動の欠乏と、
前記基準脳機能よりも低い徐波活動と、
前記基準脳機能よりも高い徐波活動と、
前記麻酔薬物の投与の下の健康な脳の基準機能に現れない脳波活動と
の中の少なくとも1つと関係づけられた前記乖離を検出するよう構成され、
前記刺激装置は、前記乖離についての前記情報の直接又は間接の受信に基づいて、前記麻酔薬物を投与された前記人間の前記脳に、脳刺激を提供するよう構成される、
請求項2に記載の装置。 - 前記刺激装置は、
前記脳に磁気的刺激を与えるためのコイルと、
前記脳に電気的刺激を与えるための電極と、
前記脳に音響的刺激を与えるための超音波振動子と、
前記脳に光刺激を与えるための装置と、及び、
前記脳に化学的刺激を与えるための投与装置と
の中の少なくとも1つを含む、
請求項1に記載の装置。 - 前記データ処理部は、前記第1の比較に基づいて前記刺激装置の刺激特性を決定するよう構成される、
請求項1に記載の装置。 - 前記データ処理部は、前記刺激装置により実行される刺激の種類と、強さと、周波数と、持続時間との中の少なくとも1つを決定するよう構成される、
請求項6に記載の装置。 - 前記データ処理部は、
推定又は計測された前記1つ以上の非ゼロ量の麻酔薬物と、前記刺激装置により行われた刺激との両方の投与の下の前記人間の脳の計測に基づく第2の脳波データを受信し、
前記第2の脳波データと、前記基準脳機能のデータ及び前記第1の脳波データの中の少なくとも1つとの間で第2の比較を行い、並びに、
前記第2の比較についての情報を提示するよう構成される、
請求項1に記載の装置。 - 前記データ処理部は、
前記第2の脳波データの徐波活動に基づいて第2の結果データを形成し、及び、
前記第2の脳波データが、前記基準脳機能のデータ及び前記第1の脳波データのうち少なくとも1つから乖離しているか否かを比較するよう構成される
請求項8に記載の装置。 - 前記データ処理部は、第2の検出に基づいて前記人間の神経機能レベルを予測し、及び予測値を提示するよう構成される、
請求項8に記載の装置。 - 前記データ処理部は、
前記第2の脳波データが、前記第1の脳波データの場合よりも基準脳活動に近い場合の、前記人間の基準神経活動機能、及び、
前記第2の脳波データが、前記第1の脳波データの場合よりも前記基準脳活動から遠い場合の、前記基準神経活動機能からの不十分な進展
のうち少なくとも1つへのさらなる進展を予測するよう構成される、
請求項10に記載の装置。 - 1つ以上のプロセッサと、
コンピュータプログラムコードを含む1つ以上のメモリとを含む装置であって、
前記1つ以上のメモリ及び前記コンピュータプログラムコードは、前記1つ以上のプロセッサにより、少なくとも、
1つ以上の非ゼロ量の麻酔薬物を投与された人間の脳の計測に基づく第1の脳波データを受信させるよう、データ処理部を制御することと、
前記第1の脳波データと基準脳機能の対応するデータとの第1の比較を行わせるよう、前記データ処理部を制御することと、
前記第1の比較についての情報を出力させるよう、前記データ処理部を制御することと、
前記第1の比較についての前記情報に基づいて、前記麻酔薬物を投与された前記人間の前記脳に脳刺激を提供させるよう、刺激装置を制御することと
を引き起こす、
装置。 - データ処理部による、1つ以上の非ゼロ量の麻酔薬物を投与された人間の脳の計測に基づく第1の脳波データを受信するステップと、
前記データ処理部による、前記第1の脳波データと基準脳機能の対応するデータとの第1の比較を実行するステップと、
前記データ処理部による、前記第1の比較についての情報を出力するステップと、
刺激装置による、前記第1の比較についての前記情報に基づいて、前記麻酔薬物を投与された前記人間の前記脳に脳刺激を提供するステップと
を含む方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/151,873 | 2016-05-11 | ||
US15/151,873 US10342450B2 (en) | 2016-05-11 | 2016-05-11 | Apparatus and method for electroencephalographic measurement |
PCT/FI2017/050243 WO2017194828A1 (en) | 2016-05-11 | 2017-04-06 | Apparatus and method for electroencephalographic measurement |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2019515777A true JP2019515777A (ja) | 2019-06-13 |
JP6817421B2 JP6817421B2 (ja) | 2021-01-20 |
Family
ID=60267526
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019511810A Active JP6817421B2 (ja) | 2016-05-11 | 2017-04-06 | 脳波計測のための装置及び方法 |
Country Status (5)
Country | Link |
---|---|
US (1) | US10342450B2 (ja) |
EP (1) | EP3454735B1 (ja) |
JP (1) | JP6817421B2 (ja) |
CN (1) | CN109152547B (ja) |
WO (1) | WO2017194828A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7329856B2 (ja) | 2018-02-14 | 2023-08-21 | セレニオン・オサケユフティオ | 脳波測定用装置および方法 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110059564B (zh) * | 2019-03-19 | 2021-01-19 | 西安交通大学 | 基于功率谱密度和互相关熵谱密度融合的特征提取方法 |
US20220369998A1 (en) * | 2019-09-19 | 2022-11-24 | B. G. Negev Technologies And Applications Ltd., At Ben-Gurion University | Methods for diagnosing and treating neural diseases |
CN113499084B (zh) * | 2021-07-09 | 2023-02-24 | 燕山大学 | 脑卒中运动功能评价模型建立方法、评价方法及系统 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6463328B1 (en) * | 1996-02-02 | 2002-10-08 | Michael Sasha John | Adaptive brain stimulation method and system |
JP2008500100A (ja) * | 2004-05-24 | 2008-01-10 | ニューロネティクス、インク. | 痙攣療法の方法および装置 |
JP2015521076A (ja) * | 2012-05-30 | 2015-07-27 | イシス イノヴェイション リミテッドIsis Innovation Limited | 知覚消失の検出 |
JP2015532153A (ja) * | 2012-10-12 | 2015-11-09 | ザ ジェネラル ホスピタル コーポレイション | 麻酔化合物の投与の間および後の患者の状態をモニターし制御するためのシステムおよび方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5315505A (en) * | 1987-08-12 | 1994-05-24 | Micro Chemical, Inc. | Method and system for providing animal health histories and tracking inventory of drugs |
US5699808A (en) * | 1994-02-07 | 1997-12-23 | New York University | EEG operative and post-operative patient monitoring system and method |
US7006620B1 (en) * | 1998-06-12 | 2006-02-28 | Sbc Properties, L.P. | System and method for routing both toll-free and caller-paid telephone calls to call service centers |
WO2009021080A2 (en) * | 2007-08-06 | 2009-02-12 | Great Lakes Biosciences, Llc | Methods and apparatus for electrical stimulation of tissues using signals that minimize the effects of tissue impedance |
US6975901B2 (en) * | 2002-09-06 | 2005-12-13 | The Brigham And Women's Hopital, Inc. | Anesthetic-state determing |
US7089927B2 (en) * | 2002-10-23 | 2006-08-15 | New York University | System and method for guidance of anesthesia, analgesia and amnesia |
WO2004100766A2 (en) | 2003-05-06 | 2004-11-25 | George Mason Intellectual Property | Phase and state dependent eeg and brain imaging |
US8825166B2 (en) * | 2005-01-21 | 2014-09-02 | John Sasha John | Multiple-symptom medical treatment with roving-based neurostimulation |
US9913976B2 (en) * | 2006-06-19 | 2018-03-13 | Highland Instruments, Inc. | Systems and methods for stimulating and monitoring biological tissue |
US7844324B2 (en) * | 2007-02-14 | 2010-11-30 | The General Electric Company | Measurement of EEG reactivity |
KR20100091196A (ko) * | 2007-10-26 | 2010-08-18 | 쓰리엠 이노베이티브 프로퍼티즈 컴파니 | 수성 결합제 또는 사이징 조성물 |
CA2666010A1 (en) | 2008-05-14 | 2009-11-14 | The Hospital For Sick Children | Methods based on fluctuations in cortical synchronization |
US20110023074A1 (en) * | 2009-07-24 | 2011-01-27 | Echostar Technologies L.L.C. | Systems and methods for facilitating antenna configuration |
CA2779842C (en) | 2009-11-04 | 2021-06-22 | Arizona Board Of Regents For And On Behalf Of Arizona State University | Devices and methods for modulating brain activity |
EP2974673B1 (en) * | 2010-03-17 | 2017-03-22 | The Board of Trustees of the University of Illionis | Implantable biomedical devices on bioresorbable substrates |
CN102793534A (zh) * | 2012-07-11 | 2012-11-28 | 广西威利方舟科技有限公司 | 麻醉深度监控装置及方法 |
WO2014152110A1 (en) | 2013-03-15 | 2014-09-25 | Simon Adam J | Multi-modal pharmaco-diagnostic assessment of brian helath |
EP2988666A1 (en) * | 2013-04-23 | 2016-03-02 | The General Hospital Corporation | System and method for monitoring anesthesia and sedation using measures of brain coherence and synchrony |
KR20160046887A (ko) | 2013-08-27 | 2016-04-29 | 헤일로우 뉴로 아이엔씨. | 전기 자극을 사용자에게 제공하기 위한 방법 및 시스템 |
-
2016
- 2016-05-11 US US15/151,873 patent/US10342450B2/en active Active
-
2017
- 2017-04-06 EP EP17795673.7A patent/EP3454735B1/en active Active
- 2017-04-06 WO PCT/FI2017/050243 patent/WO2017194828A1/en active Search and Examination
- 2017-04-06 CN CN201780028465.XA patent/CN109152547B/zh active Active
- 2017-04-06 JP JP2019511810A patent/JP6817421B2/ja active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6463328B1 (en) * | 1996-02-02 | 2002-10-08 | Michael Sasha John | Adaptive brain stimulation method and system |
JP2008500100A (ja) * | 2004-05-24 | 2008-01-10 | ニューロネティクス、インク. | 痙攣療法の方法および装置 |
JP2015521076A (ja) * | 2012-05-30 | 2015-07-27 | イシス イノヴェイション リミテッドIsis Innovation Limited | 知覚消失の検出 |
JP2015532153A (ja) * | 2012-10-12 | 2015-11-09 | ザ ジェネラル ホスピタル コーポレイション | 麻酔化合物の投与の間および後の患者の状態をモニターし制御するためのシステムおよび方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7329856B2 (ja) | 2018-02-14 | 2023-08-21 | セレニオン・オサケユフティオ | 脳波測定用装置および方法 |
Also Published As
Publication number | Publication date |
---|---|
WO2017194828A1 (en) | 2017-11-16 |
EP3454735B1 (en) | 2019-10-02 |
US20170325702A1 (en) | 2017-11-16 |
EP3454735A4 (en) | 2019-04-10 |
US10342450B2 (en) | 2019-07-09 |
EP3454735A1 (en) | 2019-03-20 |
CN109152547A (zh) | 2019-01-04 |
JP6817421B2 (ja) | 2021-01-20 |
CN109152547B (zh) | 2021-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Redinbaugh et al. | Thalamus modulates consciousness via layer-specific control of cortex | |
JP6626122B2 (ja) | 脳波を検査する装置およびその作動方法 | |
US20210290155A1 (en) | Neuromodulation method and system for sleep disorders | |
JP2020014863A (ja) | 全身麻酔および鎮静中の改良された脳監視のためのシステム | |
US7089927B2 (en) | System and method for guidance of anesthesia, analgesia and amnesia | |
Manganotti et al. | Effect of high-frequency repetitive transcranial magnetic stimulation on brain excitability in severely brain-injured patients in minimally conscious or vegetative state | |
US20140039450A1 (en) | Method and Apparatus for Treating Respiratory Disease | |
JP6817421B2 (ja) | 脳波計測のための装置及び方法 | |
JP2016520375A (ja) | 脳のコヒーレンスおよびシンクロニーの指標を使用して麻酔および鎮静を監視するためのシステムおよび方法 | |
US20120226186A1 (en) | Method for determining the level of analgesia of a sedated or narcotized individual | |
Mun-Bryce et al. | Recurring episodes of spreading depression are spontaneously elicited by an intracerebral hemorrhage in the swine | |
WO2012010173A1 (en) | An apparatus for combining drug effect interaction between anaesthetics and analgesics and electroencephalogram features for precise assessment of the level of consciousness during anaesthesia | |
Hanrahan et al. | The effects of propofol on local field potential spectra, action potential firing rate, and their temporal relationship in humans and felines | |
Simon et al. | Electroencephalography, electrocorticography, and cortical stimulation techniques | |
Ribeiro et al. | Correlation between clinical signs of depth of anaesthesia and cerebral state index responses in dogs with different target-controlled infusions of propofol | |
Redinbaugh et al. | Central thalamus modulates consciousness by controlling layer-specific cortical interactions | |
US20230381509A1 (en) | Use of Non-Invasive Sensory Systems to Titrate Cranial Nerve Stimulation to Enhance Brain Clearance Closed-Loop | |
Lonishin | EEG changes and C-Trend parameters in healthy patients during induction of anesthesia | |
RU2269291C1 (ru) | Способ оценки сенсорной чувствительности в условиях анестезии и устройство для его осуществления | |
Demoto | Comprehensive monitoring during procedures under reasonable anesthetic control | |
Gao | Integrated Cortico-Motor Features Assess Arousal in Coma Emergence in Rodents | |
Hyam et al. | The pedunculopontine region and breathing in Parkinson’s | |
Kamiya et al. | Prediction of Blood Pressure Change During Surgical Incision Under Opioid Analgesia Using a New Opioid Sensitivity Index: A Cross-Sectional Study | |
Suraphong Lorsomradee et al. | Cerebral electricalactivity as a tool in evaluating anesthetic effect during balanced anesthesia with sevoflurane | |
TW202410860A (zh) | 用於治療睡眠或運動障礙之方法及系統 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A529 | Written submission of copy of amendment under article 34 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A529 Effective date: 20181226 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20181226 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20191219 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200204 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20200501 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200617 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20201208 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20201224 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6817421 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |